Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-31

Clinical Trial Update: Effectiveness of PRP, Conditioned Medium UC-MSCs Secretome and Hyaluronic Acid for the Treatment of Knee Osteoarthritis [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating PRP, conditioned medium UC-MSCs secretome, and hyaluronic acid for knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyaluronic acid (hyaluronic acid)
  • PRP (platelet-rich plasma)
  • conditioned medium UC-MSCs secretome

Snippet

Sponsor: Universitas Sriwijaya | Conditions: Knee Osteoarthritis | Phase 1, Phase 2 | Status: COMPLETED